Search research articles
Contact Us
Filters
Showing results (151-160 of 186) with videos related to
Page
of 19
Sort By:
Breast Cancer Research and Treatment
|
June 30, 2010
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
François Bertucci, Nathalie Borie, Henri Roche, et al.
Archives of Pathology & Laboratory Medicine
|
December 8, 2024
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?
Amel Kime, Guillaume Bataillon, Isabelle Treilleux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2025
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial
Laetitia Collet, Maude Ardin, David Venet, et al.
Nature Medicine
|
April 8, 2025
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial
Olivier Trédan, Damien Pouessel, Nicolas Penel, et al.
JAMA Network Open
|
April 9, 2024
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations
Philip C Schouten, Sandra Schmidt, Kerstin Becker, et al.
Nature Communications
|
August 15, 2024
Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death
François Virard, Stéphane Giraud, Mélanie Bonnet, et al.
Journal of Personalized Medicine
|
October 27, 2022
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial
Elise Bonnet, Véronique Haddad, Stanislas Quesada, et al.
Nature Communications
|
July 16, 2024
Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial
Isabelle L Ray-Coquard, Aude-Marie Savoye, Camille Schiffler, et al.
Nature Communications
|
January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial
Isabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.
Medical Oncology (Northwood, London, England)
|
November 5, 2021
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial
Alice Bonneville-Levard, Didier Frappaz, Olivier Tredan, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 186) with videos related to
Sort By:
Page
of 19
Breast Cancer Research and Treatment
|
June 30, 2010
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
François Bertucci, Nathalie Borie, Henri Roche, et al.
Archives of Pathology & Laboratory Medicine
|
December 8, 2024
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?
Amel Kime, Guillaume Bataillon, Isabelle Treilleux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 16, 2025
Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial
Laetitia Collet, Maude Ardin, David Venet, et al.
Nature Medicine
|
April 8, 2025
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial
Olivier Trédan, Damien Pouessel, Nicolas Penel, et al.
JAMA Network Open
|
April 9, 2024
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations
Philip C Schouten, Sandra Schmidt, Kerstin Becker, et al.
Nature Communications
|
August 15, 2024
Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death
François Virard, Stéphane Giraud, Mélanie Bonnet, et al.
Journal of Personalized Medicine
|
October 27, 2022
Alterations in Homologous Recombination-Related Genes and Distinct Platinum Response in Metastatic Triple-Negative Breast Cancers: A Subgroup Analysis of the ProfiLER-01 Trial
Elise Bonnet, Véronique Haddad, Stanislas Quesada, et al.
Nature Communications
|
July 16, 2024
Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial
Isabelle L Ray-Coquard, Aude-Marie Savoye, Camille Schiffler, et al.
Nature Communications
|
January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial
Isabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.
Medical Oncology (Northwood, London, England)
|
November 5, 2021
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial
Alice Bonneville-Levard, Didier Frappaz, Olivier Tredan, et al.
Page
of 19